177 related articles for article (PubMed ID: 7797466)
1. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function.
Samis JA; Kam E; Nesheim ME; Giles AR
Blood; 1998 Aug; 92(4):1287-96. PubMed ID: 9694717
[TBL] [Abstract][Full Text] [Related]
4. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.
Lenting PJ; van de Loo JW; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1996 Jan; 271(4):1935-40. PubMed ID: 8567641
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic processing of human coagulation factor IX by plasmin.
Samis JA; Ramsey GD; Walker JB; Nesheim ME; Giles AR
Blood; 2000 Feb; 95(3):943-51. PubMed ID: 10648407
[TBL] [Abstract][Full Text] [Related]
6. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
Ahmad SS; Walsh PN
Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
[TBL] [Abstract][Full Text] [Related]
7. The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X.
Stern DM; Nawroth PP; Kisiel W; Vehar G; Esmon CT
J Biol Chem; 1985 Jun; 260(11):6717-22. PubMed ID: 3922979
[TBL] [Abstract][Full Text] [Related]
8. Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain.
Christophe OD; Lenting PJ; Kolkman JA; Brownlee GG; Mertens K
J Biol Chem; 1998 Jan; 273(1):222-7. PubMed ID: 9417068
[TBL] [Abstract][Full Text] [Related]
9. Insertion loop 256-268 in coagulation factor IX restricts enzymatic activity in the absence but not in the presence of factor VIII.
Kolkman JA; Mertens K
Biochemistry; 2000 Jun; 39(25):7398-405. PubMed ID: 10858287
[TBL] [Abstract][Full Text] [Related]
10. Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain.
Bajaj SP; Sabharwal AK; Gorka J; Birktoft JJ
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):152-6. PubMed ID: 1729682
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
[TBL] [Abstract][Full Text] [Related]
12. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
13. Mutations in hemophilia Bm occur at the Arg180-Val activation site or in the catalytic domain of factor IX.
Bertina RM; van der Linden IK; Mannucci PM; Reinalda-Poot HH; Cupers R; Poort SR; Reitsma PH
J Biol Chem; 1990 Jul; 265(19):10876-83. PubMed ID: 2162822
[TBL] [Abstract][Full Text] [Related]
14. Comparative interactions of factor IX and factor IXa with human platelets.
Ahmad SS; Rawala-Sheikh R; Walsh PN
J Biol Chem; 1989 Feb; 264(6):3244-51. PubMed ID: 2492533
[TBL] [Abstract][Full Text] [Related]
15. Kinetic comparison of bovine blood coagulation factors IXa alpha and IXa beta toward bovine factor X.
Link RP; Castellino FJ
Biochemistry; 1983 Aug; 22(17):4033-41. PubMed ID: 6412750
[TBL] [Abstract][Full Text] [Related]
16. Apparent intrinsic prothrombinase activity of human Factor X zymogen: identification with Factor VIII inhibitor bypassing activity (FEIBA).
Estry DW; Tishkoff GH
Thromb Res; 1984 Dec; 36(6):549-62. PubMed ID: 6335607
[TBL] [Abstract][Full Text] [Related]
17. Degradation of coagulation proteins by an enzyme from Malayan pit viper (Akistrodon rhodostoma) venom.
Lollar P; Parker CG; Kajenski PJ; Litwiller RD; Fass DN
Biochemistry; 1987 Dec; 26(24):7627-36. PubMed ID: 3322404
[TBL] [Abstract][Full Text] [Related]
18. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
[TBL] [Abstract][Full Text] [Related]
19. Residues Phe342-Asn346 of activated coagulation factor IX contribute to the interaction with low density lipoprotein receptor-related protein.
Rohlena J; Kolkman JA; Boertjes RC; Mertens K; Lenting PJ
J Biol Chem; 2003 Mar; 278(11):9394-401. PubMed ID: 12522212
[TBL] [Abstract][Full Text] [Related]
20. Identification of a factor IX/IXa binding protein on the endothelial cell surface.
Rimon S; Melamed R; Savion N; Scott T; Nawroth PP; Stern DM
J Biol Chem; 1987 May; 262(13):6023-31. PubMed ID: 3032954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
